Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015:2015:457326.
doi: 10.1155/2015/457326. Epub 2015 Sep 6.

Chemotherapy-Induced Nausea and Vomiting

Bernardo Leon Rapoport  1 , Alexander Molasiotis  2 , Haralambos Raftopoulos  3 , Fausto Roila  4
Affiliations
Editorial

Chemotherapy-Induced Nausea and Vomiting

Bernardo Leon Rapoport et al. Biomed Res Int. 2015.
No abstract available

PubMed Disclaimer

References

    1. Aapro M. S., Alberts D. S. Dexamethasone as an antiemetic in patients treated with cisplatin. The New England Journal of Medicine. 1981;305(9, article 520) doi: 10.1056/NEJM198108273050914. - DOI - PubMed
    1. Falkson G., van Zyl A. J. A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting. Cancer Chemotherapy and Pharmacology. 1989;24(3):193–196. doi: 10.1007/bf00300242. - DOI - PubMed
    1. Smith D. B., Newlands E. S., Spruyt O. W., et al. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. British Journal of Cancer. 1990;61(2):323–324. doi: 10.1038/bjc.1990.62. - DOI - PMC - PubMed
    1. Hesketh P. J., Grunberg S. M., Gralla R. J., et al. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin—the aprepitant protocol 052 study group. Journal of Clinical Oncology. 2003;21(22):4112–4119. doi: 10.1200/jco.2003.01.095. - DOI - PubMed
    1. Poli-Bigelli S., Rodrigues-Pereira J., Carides A. D., et al. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting: results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer. 2003;97(12):3090–3098. doi: 10.1002/cncr.11433. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources